4//SEC Filing
Skolnick Phil 4
Accession 0001385508-22-000026
CIK 0001385508other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:05 PM ET
Size
5.4 KB
Accession
0001385508-22-000026
Insider Transaction Report
Form 4
Skolnick Phil
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-01-27$26.19/sh−1,518$39,756→ 22,445 total
Footnotes (2)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $25.60 to $26.26. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
OPIANT PHARMACEUTICALS, INC.
CIK 0001385508
Entity typeother
Related Parties
1- filerCIK 0001358116
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 4:05 PM ET
- Size
- 5.4 KB